Page last updated: 2024-08-16

sch 16134 and triazolam

sch 16134 has been researched along with triazolam in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-199011 (45.83)18.7374
1990's7 (29.17)18.2507
2000's3 (12.50)29.6817
2010's3 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Mahowald, MW; Walsh, JK1
Roehrs, TA; Roth, T1
Bixler, EO; Jacoby, JA; Kales, A; Kales, JD; Soldatos, CR1
Ellinwood, EH; Heatherly, DG; Nikaido, AM1
Ellinwood, EH; Nikaido, AM1
Lader, M; Lee, A1
Gevins, AS; Ragsdale, SD; Stone, RK1
Bixler, EO; Kales, A; Manfredi, RL; Niklaus, DE; Soldatos, CR; Vela-Bueno, A1
Cooper, SJ1
Csima, A; Mamelak, M; Price, V1
Bixler, EO; Kales, A; Soldatos, CR; Vela-Bueno, A1
Carskadon, M; Dement, W; Seidel, W1
Bixler, EO; Kales, A; Kales, JD; Soldatos, CR1
Altamura, AC; Gianetti, S; Mauri, MC; Pugnetti, L1
Landy, DA1
Anderer, P; Brandstätter, N; Frey, R; Grünberger, J; Klösch, G; Mandl, M; Saletu, B; Wetter, T; Zeitlhofer, J1
Scharf, MB1
Ali, JA; Rush, CR1
Kamijima, K; Mimura, M; Nakagome, K; Okajima, Y; Otsubo, T; Shinoda, J; Takahashi, T1
Araki, N; Cui, Y; Fujimura, A; Harada, K; Kawaguchi, A; Ohmori, M; Sugimoto, K; Tsuruoka, S1
Hasegawa, C; Hayashida, M; Kurosaki, K; Ohno, Y; Shinozuka, T; Tanaka, E; Terada, M1

Reviews

4 review(s) available for sch 16134 and triazolam

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
A review of the safety profiles of benzodiazepine hypnotics.
    The Journal of clinical psychiatry, 1991, Volume: 52 Suppl

    Topics: Aged; Anti-Anxiety Agents; Benzodiazepines; Central Nervous System; Flurazepam; Half-Life; Humans; Hypnotics and Sedatives; Middle Aged; Psychomotor Performance; Sleep; Sleep Initiation and Maintenance Disorders; Temazepam; Triazolam

1991
Rebound insomnia and elimination half-life: assessment of individual subject response.
    Journal of clinical pharmacology, 1985, Volume: 25, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Half-Life; Humans; Lorazepam; Midazolam; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors; Triazolam

1985
Behavioral side effects of benzodiazepine hypnotics.
    Clinical neuropharmacology, 1985, Volume: 8 Suppl 1

    Topics: Amnesia; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Flurazepam; Humans; Hypnotics and Sedatives; Psychomotor Disorders; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Substance-Related Disorders; Triazolam

1985

Trials

10 trial(s) available for sch 16134 and triazolam

ArticleYear
Rebound insomnia and elimination half-life: assessment of individual subject response.
    Journal of clinical pharmacology, 1985, Volume: 25, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Half-Life; Humans; Lorazepam; Midazolam; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors; Triazolam

1985
Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance.
    Psychopharmacology, 1987, Volume: 92, Issue:4

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Cognition; Humans; Male; Psychomotor Performance; Triazolam

1987
Tolerance and rebound during and after short-term administration of quazepam, triazolam and placebo to healthy human volunteers.
    International clinical psychopharmacology, 1988, Volume: 3, Issue:1

    Topics: Adult; Anti-Anxiety Agents; Arousal; Attention; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Electroencephalography; Evoked Potentials; Female; Humans; Male; Psychological Tests; Psychomotor Performance; Sleep Stages; Triazolam

1988
Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.
    Clinical pharmacology and therapeutics, 1986, Volume: 40, Issue:4

    Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Half-Life; Humans; Middle Aged; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam

1986
Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
    International journal of clinical pharmacology research, 1993, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Sleep Wake Disorders; Substance Withdrawal Syndrome; Triazolam

1993
Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Neuropsychobiology, 1994, Volume: 29, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Polysomnography; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Substance Withdrawal Syndrome; Triazolam

1994
Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
    The Journal of clinical psychiatry, 1993, Volume: 54, Issue:1

    Topics: Anti-Anxiety Agents; Benzodiazepines; Circadian Rhythm; Double-Blind Method; Drug Administration Schedule; Humans; Hypnotics and Sedatives; Placebos; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam

1993
A follow-up study of the acute behavioral effects of benzodiazepine-receptor ligands in humans: comparison of quazepam and triazolam.
    Experimental and clinical psychopharmacology, 1999, Volume: 7, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Behavior; Benzodiazepines; Cognition; Cross-Over Studies; Female; Follow-Up Studies; GABA Modulators; Humans; Learning; Ligands; Male; Mental Recall; Middle Aged; Psychomotor Performance; Receptors, GABA-A; Surveys and Questionnaires; Triazolam

1999
Comparison of hangover effects among triazolam, flunitrazepam and quazepam in healthy subjects: a preliminary report.
    Psychiatry and clinical neurosciences, 2003, Volume: 57, Issue:3

    Topics: Activities of Daily Living; Adult; Anti-Anxiety Agents; Benzodiazepines; Cross-Over Studies; Fatigue; Female; Flunitrazepam; Humans; Hypnotics and Sedatives; Male; Single-Blind Method; Sleep Wake Disorders; Triazolam

2003
Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam.
    European journal of clinical pharmacology, 2006, Volume: 62, Issue:3

    Topics: Adult; Analysis of Variance; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzodiazepines; Beverages; Chromatography, High Pressure Liquid; Citrus paradisi; Cross-Over Studies; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Food-Drug Interactions; Half-Life; Humans; Hypnotics and Sedatives; Male; Metabolic Clearance Rate; Time Factors; Triazolam

2006

Other Studies

11 other study(ies) available for sch 16134 and triazolam

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Avoiding the blanket approach to insomnia. Targeted therapy for specific causes.
    Postgraduate medicine, 1991, Volume: 90, Issue:1

    Topics: Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Diagnosis, Differential; Estazolam; Flurazepam; Humans; Hypnotics and Sedatives; Sleep Initiation and Maintenance Disorders; Temazepam; Triazolam

1991
Comparative pharmacodynamics of benzodiazepines.
    Psychopharmacology series, 1987, Volume: 3

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Humans; Kinetics; Lorazepam; Male; Psychomotor Performance; Triazolam

1987
Differentiating the effects of three benzodiazepines on non-REM sleep EEG spectra. A neural-network pattern classification analysis.
    Neuropsychobiology, 1988, Volume: 19, Issue:2

    Topics: Adult; Algorithms; Anti-Anxiety Agents; Benzodiazepines; Cerebral Cortex; Electroencephalography; Evoked Potentials; Flurazepam; Humans; Male; Nerve Net; Nervous System; Signal Processing, Computer-Assisted; Sleep Stages; Triazolam

1988
Hyperphagic and anorectic effects of beta-carbolines in a palatable food consumption test: comparisons with triazolam and quazepam.
    European journal of pharmacology, 1986, Jan-29, Volume: 120, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Appetite Depressants; Benzodiazepines; Carbolines; Dose-Response Relationship, Drug; Eating; Male; Pyrazoles; Rats; Triazolam

1986
Effects of quazepam and triazolam on the sleep of chronic insomniacs: a comparative 25-night sleep laboratory study.
    Clinical neuropharmacology, 1985, Volume: 8 Suppl 1

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Drug Tolerance; Female; Humans; Male; Middle Aged; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Time Factors; Triazolam

1985
Daytime alertness, insomnia, and benzodiazepines.
    Sleep, 1982, Volume: 5 Suppl 1

    Topics: Adult; Anti-Anxiety Agents; Arousal; Benzodiazepines; Double-Blind Method; Flurazepam; Humans; Lorazepam; Male; Oxazepam; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Sleep Stages; Triazolam; Wakefulness

1982
Early morning insomnia with rapidly eliminated benzodiazepines.
    Science (New York, N.Y.), 1983, Apr-01, Volume: 220, Issue:4592

    Topics: Anti-Anxiety Agents; Benzodiazepines; Flurazepam; Half-Life; Humans; Midazolam; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam

1983
Article questioned.
    The Journal of clinical psychiatry, 1994, Volume: 55, Issue:4

    Topics: Anti-Anxiety Agents; Benzodiazepines; Humans; Peer Review; Periodicals as Topic; Placebos; Research Design; Sleep Initiation and Maintenance Disorders; Terminology as Topic; Triazolam; Writing

1994
Analysis of quazepam and its metabolites in human urine by gas chromatography-mass spectrometry: application to a forensic case.
    Forensic science international, 2013, Apr-10, Volume: 227, Issue:1-3

    Topics: Benzodiazepines; Benzodiazepinones; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Hypnotics and Sedatives; Male; Solid Phase Extraction; Substance Abuse Detection; Triazolam

2013